China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
000999
Pozycja w akcjach
#2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Cena akcji
$3.74
Kapitalizacja rynkowa
$6.23B
Zmiana (1 dzień)
-2.11%
Zmiana (1 rok)
-8.54%
Kraj
CN
Handel China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Kategoria
Healthcare
Marża operacyjna dla China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Marża operacyjna na dzień October 2026 TTM: 14.59%
Według najnowszych raportów finansowych i ceny akcji China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., bieżąca marża operacyjna (TTM) wynosi 14.59%. Na koniec 2024 wynosiła 16.20%.
Historia marży operacyjnej dla China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. od 2001 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 14.59% | -4.95% |
| 2025 | 15.35% | -5.25% |
| 2024 | 16.20% | 6.79% |
| 2023 | 15.17% | -6.93% |
| 2022 | 16.30% | 2.52% |
| 2021 | 15.90% | 4.74% |
| 2020 | 15.18% | -10.71% |
| 2019 | 17.00% | 33.96% |
| 2018 | 12.69% | -6.55% |
| 2017 | 13.58% | -4.90% |
| 2016 | 14.28% | -21.80% |
| 2015 | 18.26% | 8.18% |
| 2014 | 16.88% | -8.31% |
| 2013 | 18.41% | 1.21% |
| 2012 | 18.19% | 8.47% |
| 2011 | 16.77% | -23.95% |
| 2010 | 22.05% | 20.89% |
| 2009 | 18.24% | 24.00% |
| 2008 | 14.71% | 53.55% |
| 2007 | 9.58% | 6.44% |
| 2006 | 9.00% | 38.25% |
| 2005 | 6.51% | -124.66% |
| 2004 | -26.40% | -352.39% |
| 2003 | 10.46% | 22.05% |
| 2002 | 8.57% | 26.22% |
| 2001 | 6.79% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 19.41% | -98.67% |
DE
|
|
| 19.68% | -98.65% |
DE
|
|
| 10.52% | -99.28% |
JP
|
|
| 17.08% | -98.83% |
CH
|
|
| 22.93% | -98.43% |
IN
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.